Interleukin-4 receptor in moderate atopic asthma. A phase I/II randomized, placebo-controlled trial.
about
Pathogenesis and disease mechanisms of occupational asthmaWhat have transgenic and knockout animals taught us about respiratory disease?Th2 cytokines and asthma: an introductionTh2 cytokines and asthma. Interleukin-4: its role in the pathogenesis of asthma, and targeting it for asthma treatment with interleukin-4 receptor antagonists.Targeted anti-inflammatory therapeutics in asthma and chronic obstructive lung diseaseInterleukin-5 pathway inhibition in the treatment of eosinophilic respiratory disorders: evidence and unmet needsTherapeutic interventions in severe asthmaMonoclonal antibodies and other biologic agents in the treatment of asthmaSelf-assembling nanoparticles containing dexamethasone as a novel therapy in allergic airways inflammationKB-Rank: efficient protein structure and functional annotation identification via text queryA molecular perspective on TH2-promoting cytokine receptors in patients with allergic disease.IL-2-inducible T-cell kinase modulates TH2-mediated allergic airway inflammation by suppressing IFN-γ in naive CD4+ T cells.Recent advances: Respiratory medicine.Loss of regulator of G protein signaling 5 promotes airway hyperresponsiveness in the absence of allergic inflammation.Histamine H4 receptor antagonism diminishes existing airway inflammation and dysfunction via modulation of Th2 cytokinesBiotherapeutic targets for the treatment of allergic airway disease.Type 1/Type 2 immunity in infectious diseases.Airway remodelling in asthma: from benchside to clinical practice.Gene-gene and gene-environmental interactions of childhood asthma: a multifactor dimension reduction approach.Drug treatment of airway inflammation in asthma.Cytokines and cytokine receptors in allergic rhinitis: how do they relate to the Th2 hypothesis in allergy?Targeting interleukin-4 in asthma: lost in translation?Exhaled markers of pulmonary disease.New insights into the role of cytokines in asthmaTreatment strategies for bronchial asthma: an update.Molecular mechanisms of atopyDecreased prevalence of asthma among children with high exposure to cat allergen: relevance of the modified Th2 responseNew treatments for atopic dermatitis.Is Th1 the solution for Th2 in asthma?Soluble cytokine receptors in biological therapy.Treating the allergic patient: think globally, treat globally.New insights into the role of the mast cell in asthma.Management of asthma in adults: current therapy and future directionsDrug development for asthma.Consensus Group on New-Generation Antihistamines (CONGA): present status and recommendations.Biologic therapies targeting eosinophils: current status and future prospects.New targets for allergic rhinitis--a disease of civilization.Anti-interleukin-5 monoclonal antibodies: preclinical and clinical evidence in asthma models.Asthma refractory to glucocorticoids: the role of newer immunosuppressants.New strategies in the treatment and prevention of allergic diseases.
P2860
Q23924178-333EF88F-380E-49BF-B29B-11DB29882097Q24791345-98F3B0D4-24EB-434D-A886-45E4840A0149Q24791803-D3552702-F9DA-401E-97D7-C9ACED72F83CQ24791820-3DDBC3DC-1605-4A6E-9F1B-05D4C2066342Q26786229-B9315776-BB04-4617-BE75-EFD6C9302BEEQ28067081-35E04FE3-F011-4300-9A64-CBAE0362D2E5Q28079238-7A31F1FA-076D-4F05-BD6D-CC26BD541516Q28270037-B38D0703-0C45-4C44-BDC6-65EEB059CA4DQ28534642-F7E66D0B-5A6E-498D-9B0F-4A08875E48ABQ28728482-DA52BCD3-4A17-4F09-8D88-F70BE225B2BEQ30406072-C9219106-2260-4B3C-8702-71FFB64AE688Q33660094-0BC842B5-5D2D-41F1-9A55-70D7F1184DD3Q33808282-01D291F5-B3FC-4872-B133-B8159C43F565Q33993700-C9FF94E0-C79F-472D-85C3-F7ED1F665DBBQ34039588-E04CF9E4-847D-445E-8C60-09245CC25BEDQ34058685-AF140333-1272-4B72-AF4A-5A40EF8EBF43Q34105379-563EDFB0-6737-407D-A364-DF01FABC88DFQ34105688-CA4498DD-6A91-417C-B993-08A904F08D13Q34166205-70842512-A4A1-46CE-8EF0-894F2235C497Q34186818-C26B62CE-8042-4F7C-8726-A59FF48E9BC3Q34190513-85C078F3-ACDB-4952-87BD-902362C7C9F7Q34271232-5F58ACF2-30CD-40B5-813C-66944E2C6D94Q34279117-BC37EF66-C44F-43C6-8255-453C7E4775ECQ34321721-2421E53C-ABBE-4D52-ADB2-5BC99C7B4A56Q34342572-290C28C3-DFE7-47C6-A067-28B6BD007D82Q34510796-20232C0D-AE27-4590-9773-02D5832B7A0DQ34510803-200AA893-14FF-4F4F-A0BB-15384C4FA251Q34592295-AEAC741E-6830-4279-BFCC-3FA65A007CCDQ34632441-229FC8B0-2A73-4810-84F7-ED5B2D4465B7Q34779777-A9B56C41-4D83-45F7-98DD-B46F3000E188Q34881155-B7E47563-8D1B-4901-8A33-D2A654E43CFBQ35129653-1550459E-C656-4E25-9527-6CC00BB25F77Q35143482-38347B39-29F6-410D-8F4A-32DDB316A5A2Q35183997-580D1648-3BB5-4A82-9AFB-F39598616C75Q35212261-3359C0AE-CF95-4671-A2A0-C1DCC16460BEQ35565533-A42BE1EB-CC1B-4921-BF7B-BD585C7403B9Q35605442-A9D9CB30-F047-4F43-9680-77A8F1F0AB8FQ35627697-FE8EB5A4-5FBC-4E78-A8E3-DD1FB87DBB42Q35627919-983E4C6F-E3F5-4309-A8AA-DC9A1076A143Q35680646-BB9EF651-C4C6-40FD-A401-0343DD5124EA
P2860
Interleukin-4 receptor in moderate atopic asthma. A phase I/II randomized, placebo-controlled trial.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh-hant
name
Interleukin-4 receptor in mode ...... zed, placebo-controlled trial.
@en
Interleukin-4 receptor in mode ...... zed, placebo-controlled trial.
@nl
type
label
Interleukin-4 receptor in mode ...... zed, placebo-controlled trial.
@en
Interleukin-4 receptor in mode ...... zed, placebo-controlled trial.
@nl
prefLabel
Interleukin-4 receptor in mode ...... zed, placebo-controlled trial.
@en
Interleukin-4 receptor in mode ...... zed, placebo-controlled trial.
@nl
P2093
P2860
P921
P1476
Interleukin-4 receptor in mode ...... zed, placebo-controlled trial.
@en
P2093
H S Nelson
J B Whitmore
J M Agosti
L Claussen
L Garrison
P2860
P304
P356
10.1164/AJRCCM.160.6.9808146
P407
P577
1999-12-01T00:00:00Z